000 01419 a2200373 4500
005 20250512084829.0
264 0 _c19851114
008 198511s 0 0 eng d
022 _a0277-3732
024 7 _a10.1097/00000421-198506000-00013
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aPoydock, M E
245 0 0 _aMitogenic inhibition and effect on survival of mice bearing L1210 leukemia using a combination of dehydroascorbic acid and hydroxycobalamin.
_h[electronic resource]
260 _bAmerican journal of clinical oncology
_cJun 1985
300 _a266-9 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aAnimals
650 0 4 _aAntineoplastic Combined Chemotherapy Protocols
_xtherapeutic use
650 0 4 _aCell Division
_xdrug effects
650 0 4 _aCells, Cultured
650 0 4 _aDehydroascorbic Acid
_xadministration & dosage
650 0 4 _aDrug Evaluation, Preclinical
650 0 4 _aFemale
650 0 4 _aHydroxocobalamin
_xadministration & dosage
650 0 4 _aLeukemia L1210
_xdrug therapy
650 0 4 _aMice
650 0 4 _aMice, Inbred DBA
700 1 _aHarguindey, S
700 1 _aHart, T
700 1 _aTakita, H
700 1 _aKelly, D
773 0 _tAmerican journal of clinical oncology
_gvol. 8
_gno. 3
_gp. 266-9
856 4 0 _uhttps://doi.org/10.1097/00000421-198506000-00013
_zAvailable from publisher's website
999 _c4056429
_d4056429